FDA Warns That Thermal Imaging Systems Pose a Potential Danger to Public Health
- Wall Street ends week positively; S&P 500, Dow hit record highs
- Bitcoin (BTC) Drops 3% as Turkey Bans Cryptocurrency Payments Citing Lack of Regulatory Supervision
- Morgan Stanley (MS) Archegos-Related Loss Appears to be $911M
- Dollar at 4-week low on retreating Treasury yields
- J&J (JNJ) Privately Asked Rival Covid-19 Vaccine Makers to Inspect Clotting Risks, AstraZeneca (AZN) Said Yes but Pfizer (PFE) and Moderna (MRNA) Declined - Report
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
The U.S. Food and Drug Administration (FDA) announced that improper use of thermal imaging systems that measure human body temperature, also known as thermal cameras, may provide inaccurate and unreliable temperature readings. Additionally, the FDA issued Warning Letters to certain firms offering unapproved, uncleared, and unauthorized thermal imaging systems for sale. During the pandemic, non-contact thermal imaging have been used broadly when screening for fever, the #1 COVID-19 symptom. These public screenings have persisted in spite of a large body of scientific research proving their ineffectiveness in obtaining accurate temperature readings.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Analysis: Countries seek more Moderna, Pfizer/BioNTech COVID-19 shots as concerns mount over rival vaccines
- AVEO Announces Appointment of Kevin Cullen, M.D., to Its Board of Directors
- Akers Biosciences (AKER), MyMD Pharmaceuticals Announce Stockholder Approval of Merger
Create E-mail Alert Related CategoriesCorporate News, FDA
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!